| First-in-human Study in Healthy Subjects (NCT03315338) | Corcept Therapeutics | 2017-09-15 |
| A Study of the Abuse Potential of Lasmiditan in Participants Who Are Recreational Drug Users (NCT03286218) | Eli Lilly and Company | 2017-09-15 |
| Lidocaine for Oxaliplatin-induced Neuropathy (NCT03254394) | Washington University School of Medicine | 2017-09-15 |
| Pembrolizumab and Exemestane/ Leuprolide in Premenopausal HR+/ HER2- Locally Advanced or Metastatic Breast Cancer (NCT02990845) | National Taiwan University Hospital | 2017-09-15 |
| A Study of PD-L1 Antibody KN035 in Japanese Subjects With Locally Advanced or Metastatic Solid Tumors (NCT03248843) | 3D Medicines (Sichuan) Co., Ltd. | 2017-09-15 |
| DAW1033B2 in Obstructive Sleep Apnea (NCT03426631) | Brigham and Women's Hospital | 2017-09-15 |
| Study of Radiolabeled Danicopan in Healthy Male Participants (NCT04889391) | Alexion Pharmaceuticals, Inc. | 2017-09-14 |
| Evaluate the Pharmacokinetic Characteristics and Safety/Tolerability of YNP-1807 Compared to Lyrica® After Oral Administration Adult Volunteers (NCT03261427) | Yungjin Pharm. Co., Ltd. | 2017-09-14 |
| Safety and Tolerability Study for T-1101 (Tosylate) to Treat Advanced Refractory Solid Tumors (NCT03195764) | Taivex Therapeutics Corporation | 2017-09-14 |
| Study of High Efficient Killing Cell Therapy for Advanced NSCLC (NCT03193567) | Ruijin Hospital | 2017-09-14 |
| An Extension Study for T-1101 (Tosylate) to Treat Advanced Refractory Solid Tumors (NCT03349073) | Taivex Therapeutics Corporation | 2017-09-14 |
| A Phase IB/II Study of Alectinib Combined With Cobimetinib in Advanced ALK-Rearranged (ALK+) NSCLC (NCT03202940) | Massachusetts General Hospital | 2017-09-14 |
| A Dose Escalation Study of Carfilzomib Taken With Thalidomide and Dexamethasone in Relapsed AL Amyloidosis (NCT02545907) | University College, London | 2017-09-14 |
| A Study to Assess the Pharmacodynamic Effects of SAGE-217 in Healthy Adults Using an Insomnia Model (NCT03284931) | Biogen | 2017-09-14 |
| Proximod Pharmacokinetics In Healthy Subjects (NCT06361186) | Longevity Inc. | 2017-09-14 |
| Study to Evaluate the Safety and Anti-tumor Activity of SCC244 (NCT03466268) | Haihe Biopharma Co., Ltd. | 2017-09-14 |
| A Study Evaluates the Safety, Pharmacokinetics and Efficacy of WX-0593 in Advanced Solid Tumor Patients (NCT03389815) | Qilu Pharmaceutical Co., Ltd. | 2017-09-14 |
| A Phase I Study of TQ-B3395 on Tolerance and Pharmacokinetics (NCT02944864) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2017-09-13 |
| A Study of Crisaborole Ointment 2% in Adult Japanese Healthy Subjects and Adult Japanese Subjects With Mild To Moderate Atopic Dermatitis (NCT03260595) | Pfizer | 2017-09-13 |
| 3BNC117-LS First-in-Human Phase 1 Study (NCT03254277) | Rockefeller University | 2017-09-13 |
| A Study to Evaluate BMS-986165 Tablet Formulation Relative to BMS-986165 Capsule Formulation and the Effect of a High-Fat/ High-Calorie Meal and Increased Gastric pH on the BMS-986165 Tablet Formulation (NCT03254784) | Bristol-Myers Squibb | 2017-09-13 |
| PRS-343 in HER2-Positive Solid Tumors (NCT03330561) | Pieris Pharmaceuticals, Inc. | 2017-09-13 |
| D-0120 Safety and PK/PD, Food Effect Study in Healthy Volunteers (NCT03291782) | InventisBio Co., Ltd | 2017-09-13 |
| A Study of SC-007 in Subjects With Advanced Cancer (NCT03253185) | AbbVie | 2017-09-13 |
| Clinical Efficacy and Safety of NK and NKT Cells Infusion in Patients With Non Small Cell Lung Cancer (NCT03198923) | Wenxiang Wang | 2017-09-13 |
| Study to Evaluate the Effect of UGT Inhibition by Valproic Acid on the Pharmacokinetics of BIIB074 (NCT03385525) | Biogen | 2017-09-12 |
| A Study to Investigate the Regional Brain Kinetics of the Positron Emission Tomography Ligand [18F]JNJ-64511070 (NCT03270579) | Janssen Research & Development, LLC | 2017-09-12 |
| A Study of OMP-336B11 in Subjects With Locally Advanced or Metastatic Tumors (NCT03295942) | OncoMed Pharmaceuticals, Inc. | 2017-09-12 |
| A Study of PLX2853 in Advanced Malignancies. (NCT03297424) | Opna Bio LLC | 2017-09-12 |
| Radiolabeled Study of CC-220 in Healthy Male Subjects (NCT03294603) | Celgene | 2017-09-11 |
| Single and Multiple Ascending Dose Study Assessing the Safety, Tolerability, PK and PD of AG10 (NCT03294707) | Eidos Therapeutics, a BridgeBio company | 2017-09-11 |
| Biomarkers Predicting Infectivity in an Experimental Human Influenza Model (NCT03207152) | Duke University | 2017-09-11 |
| A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Odalasvir and AL-335 Alone and in Combination With Simeprevir in Participants With Moderately Impaired Hepatic Function (NCT03277755) | Janssen Research & Development, LLC | 2017-09-11 |
| A Study to Evaluate the Bioavailability of Risankizumab Following Subcutaneous Dosing in Healthy Male Participants (NCT05283694) | AbbVie | 2017-09-11 |
| PK Study in Adult Healthy Volunteers to Assess QD Dosing With the Selected Age-appropriate MR Formulations (NCT03112148) | Pfizer | 2017-09-11 |
| Placebo-Controlled Single Dose Study to Evaluate Safety and Pharmacokinetics of SXC-2023 in Healthy Volunteers (NCT03301298) | Promentis Pharmaceuticals, Inc. | 2017-09-11 |
| The Effect of BMS-986195 Combined With an Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female Patients (NCT03262740) | Bristol-Myers Squibb | 2017-09-11 |
| The Feasibility of Propofol TCI in Hemodialysis Patients Undergoing Arteriovenous Shunt Surgery (NCT03311581) | Kaohsiung Medical University Chung-Ho Memorial Hospital | 2017-09-11 |
| A Repeat Insult Patch Test (RIPT) Study Evaluating the Sensitization Potential of Topical SM04755 Solution in Healthy Volunteers (NCT03502434) | Biosplice Therapeutics, Inc. | 2017-09-11 |
| Study of NGM313 in Obese Participants (NCT03298464) | NGM Biopharmaceuticals, Inc | 2017-09-11 |
| Safety Study of Human Neural Stem Cells Injections for Secondary Progressive Multiple Sclerosis Patients (NCT03282760) | Casa Sollievo della Sofferenza IRCCS | 2017-09-09 |
| REirradiation and Programmed Cell Death Protein 1 (PD-1) Blockade On Recurrent Squamous Cell Head and Neck Tumors (NCT03317327) | Oslo University Hospital | 2017-09-09 |
| Ceritinib + Trametinib in Patients With Advanced ALK-Positive Non-Small Cell Lung Cancer (NSCLC) (NCT03087448) | University of California, San Francisco | 2017-09-09 |
| Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin (NCT03686722) | Mohamed Raslan | 2017-09-09 |
| Clinical Study of ET190L1 ARTEMIS™ in Relapsed, Refractory B Cell Lymphoma (NCT03415399) | Eureka Therapeutics Inc. | 2017-09-09 |
| Bioavailability and Food Effect Study of Two Formulations of PF-06650833 (NCT03308110) | Pfizer | 2017-09-08 |
| Activity of MK-8504 in Anti-retroviral-naïve, Human Immunodeficiency Virus 1 (HIV-1) Infected Participants (MK-8504-002) (NCT03188523) | Merck Sharp & Dohme LLC | 2017-09-08 |
| Autologous CD8+ SLC45A2-Specific T Lymphocytes With Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating Patients With Metastatic Uveal Melanoma (NCT03068624) | M.D. Anderson Cancer Center | 2017-09-08 |
| A Study to Evaluate the Reactogenicity, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Supra-seasonal Universal Influenza Vaccines - Inactivated (SUIVs) (GSK3816302A) in Healthy Adults Aged 18 to 39 Years (NCT03275389) | GlaxoSmithKline | 2017-09-08 |
| A Multiple-dose Study of ASP8374, an Immune Checkpoint Inhibitor, as a Single Agent and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors (NCT03260322) | Astellas Pharma Global Development, Inc. | 2017-09-08 |
| Assessing Safety and Efficacy of DE-089 Ophthalmic Solution in Patients With Dry Eye Disease (NCT03216096) | Santen Pharmaceutical Co., Ltd. | 2017-09-08 |
| Magrolimab Monotherapy or Magrolimab in Combination With Azacitidine in Participants With Hematological Malignancies (NCT03248479) | Gilead Sciences | 2017-09-08 |
| Evaluation of Erythroferrone as a New Biomarker of Erythropoesis Stimulating Agents (NCT03276910) | Association Athletes For Transparency | 2017-09-08 |
| To Compare the Gastrointestinal Safety of a 14-Day Oral Dosing Regimen of ATB-346 to Sodium Naproxen in Healthy Subjects (NCT03291418) | Antibe Therapeutics Inc. | 2017-09-08 |
| Gene Transfer Clinical Study in Crigler-Najjar Syndrome (NCT03223194) | Audentes Therapeutics | 2017-09-08 |
| A Trial to Find the Safe Dose for BI 891065 Alone and in Combination With BI 754091 in Patients With Incurable Tumours or Tumours That Have Spread (NCT03166631) | Boehringer Ingelheim | 2017-09-08 |
| A Study Of Avelumab In Combination With Axitinib In Advanced HCC (VEGF Liver 100) (NCT03289533) | Pfizer | 2017-09-08 |
| Study of the Safety and Efficacy of MIW815 With PDR001 in Patients With Advanced/Metastatic Solid Tumors or Lymphomas (NCT03172936) | Novartis Pharmaceuticals | 2017-09-08 |
| Ketamine as an Adjunctive Therapy for Major Depression (NCT03256162) | St Patrick's Hospital, Ireland | 2017-09-07 |
| Tolerability, Safety and Pharmacokinetics Study of GX-30 in Total Thyroidectomy or Near Total Thyroidectomy Patients (NCT03276988) | Genexine, Inc. | 2017-09-07 |
| Concurrent or Sequential Immunotherapy and Radiation Therapy in Patients With Metastatic Lung Cancer (NCT03223155) | University of Chicago | 2017-09-07 |
| A Study of AL-034 to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses in Healthy Participants (NCT03285620) | Alios Biopharma Inc. | 2017-09-07 |
| Study of Nintedanib and Chemotherapy for Advanced Pancreatic Cancer (NCT02902484) | University of Texas Southwestern Medical Center | 2017-09-07 |
| Glasdegib Absolute Bioavailability Study (NCT03270878) | Pfizer | 2017-09-07 |
| Nivolumab Plus Rituximab in First-line Follicular Lymphoma gr 1-3A (NCT03245021) | Dr. Eliza Hawkes | 2017-09-07 |
| Lipopolysaccharide (LPS) Challenge in Depression (NCT03142919) | Laureate Institute for Brain Research, Inc. | 2017-09-07 |
| Clinical Trial of OPB-111077 in Patients With Relapsed or Refractory Acute Myeloid Leukaemia (NCT03197714) | Hospital Universitario 12 de Octubre | 2017-09-07 |
| A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies (NCT02963831) | Ludwig Institute for Cancer Research | 2017-09-07 |
| Phase I to Test a New Pneumococcal Vaccine (NCT03303976) | LimmaTech Biologics AG | 2017-09-07 |
| Topical Infliximab for Sterile Corneal Melt (NCT02987686) | Centre hospitalier de l'Université de Montréal (CHUM) | 2017-09-06 |
| Treatment of Dry Age Related Macular Degeneration Disease With Retinal Pigment Epithelium Derived From Human Embryonic Stem Cells (NCT03046407) | Chinese Academy of Sciences | 2017-09-06 |
| Autologous Mesenchymal Stem Cells Transplantation in Cervical Chronic and Complete Spinal Cord Injury (NCT02574572) | Hospital Sao Rafael | 2017-09-06 |
| Safety, Tolerability, and Pharmacokinetics of Proxalutamide Therapy in Women With Metastatic Breast Cancer (NCT04103853) | Suzhou Kintor Pharmaceutical Inc, | 2017-09-06 |
| Storytelling Narrative Communication Intervention for Smoking Cessation in Women Living With HIV (NCT03289676) | University of Massachusetts, Boston | 2017-09-06 |
| M3541 in Combination With Radiotherapy in Solid Tumors (NCT03225105) | EMD Serono Research & Development Institute, Inc. | 2017-09-06 |
| A Study to Investigate the Effect of Single Dose of AZD6094 (600 mg) on Cardiac Repolarization in Healthy Volunteers (NCT03258515) | AstraZeneca | 2017-09-06 |
| Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source (NCT03109041) | CivaTech Oncology | 2017-09-06 |
| A Study of Brentuximab Vedotin + Adriamycin, Vinblastine, and Dacarbazine in Pediatric Participants With Advanced Stage Newly Diagnosed Hodgkin Lymphoma (NCT02979522) | Takeda | 2017-09-06 |
| Phase 1A Safety Trial of Inhaled PK10571 (GB002) (NCT03473236) | GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. | 2017-09-06 |
| PM14 Administered Intravenously to Patients With Advanced Solid Tumors (NCT05076396) | PharmaMar | 2017-09-06 |
| A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects (NCT03279146) | ContraVir Pharmaceuticals, Inc. | 2017-09-06 |
| Effect of Lorcaserin on Cannabis Withdrawal and Self-administration (NCT03253926) | New York State Psychiatric Institute | 2017-09-05 |
| Ipilimumab and Decitabine in Treating Patients With Relapsed or Refractory Myelodysplastic Syndrome or Acute Myeloid Leukemia (NCT02890329) | National Cancer Institute (NCI) | 2017-09-05 |
| Cluster of Differentiation Antigen 19/22(CD19/22) CAR T Cells (AUTO3) for the Treatment of Diffuse Large B Cell Lymphoma (NCT03287817) | Autolus Limited | 2017-09-05 |
| A Study to Evaluate the Pharmacokinetics in Participants After Dosing With Pegilodecakin (LY3500518) (NCT03267732) | Eli Lilly and Company | 2017-09-05 |
| Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia (NCT02948283) | City of Hope Medical Center | 2017-09-05 |
| A Study of Blinatumomab in Patients With Pre B-cell ALL and B-cell NHL as Post-allo-HSCT Remission Maintenance (NCT03114865) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-09-05 |
| Phase 1 Clinical Trial of the Safety and Immunogenicity of an Adenovirus-based TB Vaccine Administered by Aerosol (NCT02337270) | McMaster University | 2017-09-05 |
| NANT 2015-02: A Phase 1 Study of Lorlatinib (PF-06463922) (NCT03107988) | New Approaches to Neuroblastoma Therapy Consortium | 2017-09-05 |
| A Study of ABT-199 Plus Ibrutinib and Rituximab in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (NCT03136497) | Hackensack Meridian Health | 2017-09-05 |
| Narcotic vs. Non-narcotic Pain Regimens After Pediatric Appendectomy (NCT03528343) | University of Utah | 2017-09-05 |
| Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors (NCT03170960) | Exelixis | 2017-09-05 |
| Phase I/IIa Study of Concomitant Radiotherapy With Olaparib and Temozolomide in Unresectable High Grade Gliomas Patients (NCT03212742) | Centre Francois Baclesse | 2017-09-04 |
| This Study Tests BI 685509 in Healthy Chinese and Japanese Men; the Study Tests How Different Doses of BI 685509 Are Taken up in the Body and How Well They Are Tolerated (NCT03259464) | Boehringer Ingelheim | 2017-09-04 |
| First-in-Human Trial of Anti-ADAMTS-5 Nanobody in Healthy Volunteers (NCT03224702) | Merck KGaA, Darmstadt, Germany | 2017-09-04 |
| Trial to Evaluate the PK Profile of Glepaglutide (ZP1848) After a Single IV and After Multiple SC Injections in Healthy Subjects (NCT03279302) | Zealand Pharma | 2017-09-04 |
| 36 Weeks Short-Term Optimization Treatment of Glucocorticosteroid in the Patients With Chronic Recurrent DILI (NCT03266146) | Beijing 302 Hospital | 2017-09-02 |
| A Dose Escalation and Combination Immunotherapy Study to Evaluate BMS-986226 Alone or in Combination With Nivolumab or Ipilimumab in Patients With Advanced Solid Tumors (NCT03251924) | Bristol-Myers Squibb | 2017-09-01 |
| Pharmacokinetics of Cefepime and AAI101 in Subjects With Renal Insufficiency and Healthy Subjects (NCT03680352) | Allecra | 2017-09-01 |
| TMTP1-ICG Mapping in Laparoscopic SLN Detection in Cervical Cancer (NCT03321448) | Huazhong University of Science and Technology | 2017-09-01 |